Question follow-through · 53426

Infant Foods

To ask the Secretary of State for Health and Social Care, what steps he is taking to update the existing regulations on (a) composition, (b) marketing and (c) labelling of commercial infant and toddler foods to ensure products are suitably nutritious.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
19 May 2025
Target answer date
21 May 2025
Answer
28 May 2025 · 9 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 19 May 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, what steps he is taking to update the existing regulations on (a) composition, (b) marketing and (c) labelling of commercial infant and toddler foods to ensure products are suitably nutritious.

  2. 21 May 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 28 May 2025

    Answer published

    Children’s early years provide an important foundation for their future health and strongly influences many aspects of wellbeing in later life.It is vital that we maintain the highest standards for foods consumed by babies and infants, which is why we hav...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Prostate Cancer: Hormone Treatments

2 Jul 2025 · To ask the Secretary of State for Health and Social Care, with reference to the randomised control trial study report entitled Cost utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long term hormone therapy in newly diagnosed

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Prostate Cancer: Hormone Treatments

2 Jul 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of NHS England’s decision not to commission abiraterone acetate plus prednisone/prednisolone for men with high risk non metastatic prostate cance

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Ambulance Services: Mental Health Services

9 Jul 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of adequacy of the (a) support available to ambulance staff who attend traumatic callouts and (b) suicide prevention training provided to ambulance staff.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Innovation: Beer and Public Houses

9 Jul 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of innovation in the beer and pub sector with the (a) development and (b) availability of (i) no and (ii) low alcohol products on the aims of the

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Prostate Cancer: Hormone Treatments

16 Jul 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 July 2025 to Question 64682 on Prostate Cancer: Hormone Treatments, if his Department will publish the Equality and Health Inequalities Impact Assessment for abirateron

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Radiotherapy

18 Jul 2025 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of establishing a national radiotherapy advisory group.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Radiotherapy: Medical Equipment

18 Jul 2025 · To ask the Secretary of State for Health and Social Care, if he will take steps to include policies on replacing older radiotherapy machines in the national cancer plan.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Prostate Cancer: Hormone Treatments

1 Sept 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 July 2025 to Question 64681 on Prostate Cancer: Hormone Treatments, for what reason recurrent headroom in revenue budgets is considered a barrier to implementing the abi

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Clinical Priorities Advisory Group

11 Sept 2025 · To ask the Secretary of State for Health and Social Care, whether the Clinical Priorities Advisory Group has a budget to approve new treatments.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Medical Treatments

10 Oct 2025 · To ask the Secretary of State for Health and Social Care, whether there is a facility for the NHS to approve treatments without external payment for assessment by the National Institute for Health and Care Excellence.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Rare Cancers: Diagnosis

14 Oct 2025 · To ask the Secretary of State for Health and Social Care, how the full roll-out of the non-specific symptom pathways is being measured; and how their development has included the less survivable cancers.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Rare Cancers: Medical Treatments

14 Oct 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of minimally invasive therapies for the less survivable cancers.